Posts for Protalix BioTherapeutics, Inc. ($PLX)

Showing 1 - 2 of 2 Posts

Protalix BioTherapeutics 8-K Report: Key Developments & Stock Insights

•

Form 8-K

•

2024-12-31

Last updated: 4 months ago

Protalix BioTherapeutics 8-K Report: Key Developments & Stock Insights

Explore Protalix BioTherapeutics' latest 8-K filing dated December 27, 2024. Discover essential updates, stock performance, and company insights for investors.

Protalix BioTherapeutics biotechnology 8-K filing common stock NYSE American

Protalix BioTherapeutics 8-K Report: Key Update on December 23, 2024

•

Form 8-K

•

2024-12-23

Last updated: 4 months ago

Protalix BioTherapeutics 8-K Report: Key Update on December 23, 2024

Discover Protalix BioTherapeutics' significant 8-K filing. Learn about their current stock status, updates, and what it means for investors. Stay informed!

Protalix BioTherapeutics biotechnology NYSE American 8-K filing healthcare